| First Author | Wellford SA | Year | 2022 |
| Journal | Immunity | Volume | 55 |
| Issue | 11 | Pages | 2118-2134.e6 |
| PubMed ID | 36137543 | Mgi Jnum | J:335984 |
| Mgi Id | MGI:7386640 | Doi | 10.1016/j.immuni.2022.08.017 |
| Citation | Wellford SA, et al. (2022) Mucosal plasma cells are required to protect the upper airway and brain from infection. Immunity 55(11):2118-2134.e6 |
| abstractText | While blood antibodies mediate protective immunity in most organs, whether they protect nasal surfaces in the upper airway is unclear. Using multiple viral infection models in mice, we found that blood-borne antibodies could not defend the olfactory epithelium. Despite high serum antibody titers, pathogens infected nasal turbinates, and neurotropic microbes invaded the brain. Using passive antibody transfers and parabiosis, we identified a restrictive blood-endothelial barrier that excluded circulating antibodies from the olfactory mucosa. Plasma cell depletions demonstrated that plasma cells must reside within olfactory tissue to achieve sterilizing immunity. Antibody blockade and genetically deficient models revealed that this local immunity required CD4(+) T cells and CXCR3. Many vaccine adjuvants failed to generate olfactory plasma cells, but mucosal immunizations established humoral protection of the olfactory surface. Our identification of a blood-olfactory barrier and the requirement for tissue-derived antibody has implications for vaccinology, respiratory and CNS pathogen transmission, and B cell fate decisions. |
